Pharmaceutical researchers are developing 258 new medicines for diseases that disproportionately affect the nation’s 42.6 million Hispanic Americans, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA). The report was conducted in cooperation with the Interamerican College of Physicians and Surgeons and the National Alliance for Hispanic Health.